
Sign up to save your podcasts
Or
Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.
3.9
122122 ratings
Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.
326 Listeners
159 Listeners
866 Listeners
492 Listeners
277 Listeners
3,322 Listeners
87 Listeners
135 Listeners
1,087 Listeners
186 Listeners
514 Listeners
349 Listeners
245 Listeners
424 Listeners
366 Listeners